{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:31:25Z","timestamp":1790253085069,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xops.2025.101028","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T08:03:22Z","timestamp":1764662602000},"page":"101028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Longitudinal Study of Macular Preservation and Geographic Atrophy Progression in Age-Related Eye Disease Study 2"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7091-7144","authenticated-orcid":false,"given":"Sairi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6773-1189","authenticated-orcid":false,"given":"Thomas F.","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5466-8829","authenticated-orcid":false,"given":"Karl G.","family":"Csaky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"Agr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiarn\u00e1n D.L.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0999-9802","authenticated-orcid":false,"given":"Emily Y.","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Blodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8145-9619","authenticated-orcid":false,"given":"Amitha","family":"Domalpally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2025.101028_bib1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/ICU.0000000000000952","article-title":"Identifying geographic atrophy","volume":"34","author":"Clevenger","year":"2023","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.xops.2025.101028_bib2","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1001\/jamaophthalmol.2022.4401","article-title":"Prevalence of age-related macular degeneration in the us in 2019","volume":"140","author":"Rein","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.101028_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2017.08.038","article-title":"The progression of geographic atrophy secondary to age-related macular degeneration","volume":"125","author":"Fleckenstein","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.101028_bib4","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1097\/IAE.0000000000003796","article-title":"Complement inhibition for geographic atrophy: review of salient functional outcomes and perspective","volume":"43","author":"Spaide","year":"2023","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.101028_bib5","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/S0140-6736(23)01520-9","article-title":"Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (oaks and derby): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials","volume":"402","author":"Heier","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.xops.2025.101028_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2025.12.011","article-title":"Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 2-year efficacy and safety results from the GATHER2 phase 3 trial","author":"Khanani","year":"2026","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.101028_bib8","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1097\/IAE.0000000000001283","article-title":"Clinical endpoints for the study of geographic atrophy secondary to age-related macular degeneration","volume":"36","author":"Sadda","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.xops.2025.101028_bib9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/2474126419859454","article-title":"Percentage of foveal vs total macular geographic atrophy as a predictor of visual acuity in age-related macular degeneration","volume":"3","author":"Bagheri","year":"2019","journal-title":"J Vitreoretin Dis"},{"key":"10.1016\/j.xops.2025.101028_bib10","doi-asserted-by":"crossref","first-page":"BIO61","DOI":"10.1167\/iovs.16-21210","article-title":"Combined fundus autofluorescence and near infrared reflectance as prognostic biomarkers for visual acuity in foveal-sparing geographic atrophy","volume":"58","author":"Lindner","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.101028_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.oret.2020.01.019","article-title":"Visual function decline resulting from geographic atrophy: results from the chroma and spectri phase 3 trials","volume":"4","author":"Heier","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2025.101028_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ajo.2024.02.021","article-title":"Drug approval for the treatment of geographic atrophy: how we got here and where we need to go","volume":"263","author":"Csaky","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.101028_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41433-024-03443-0","article-title":"Age-related macular degeneration: natural history revisited in geographic atrophy","volume":"39","author":"Broadbent","year":"2025","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2025.101028_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ajo.2017.03.031","article-title":"Geographic atrophy and foveal-sparing changes related to visual acuity in patients with dry age-related macular degeneration over time","volume":"179","author":"Sayegh","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.101028_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000445217","article-title":"Modeling visual acuity in geographic atrophy secondary to age-related macular degeneration","volume":"235","author":"Schmitz-Valckenberg","year":"2016","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.xops.2025.101028_bib16","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archophthalmol.2009.198","article-title":"Change in area of geographic atrophy in the age-related eye disease study: areds report number 26","volume":"127","author":"Lindblad","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.xops.2025.101028_bib17","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.oret.2020.11.003","article-title":"Relationship of topographic distribution of geographic atrophy to visual acuity in nonexudative age-related macular degeneration","volume":"5","author":"Shen","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.xops.2025.101028_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100871","article-title":"Investigating macular tissue integrity index as a novel biomarker in geographic atrophy","volume":"5","author":"Erb","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2025.101028_bib19","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ophtha.2012.05.027","article-title":"The age-related eye disease study 2 (areds2): study design and baseline characteristics (areds2 report number 1)","volume":"119","author":"Group","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.101028_bib20","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.ophtha.2016.06.025","article-title":"Evaluation of geographic atrophy from color photographs and fundus autofluorescence images: age-related eye disease study 2 report number 11","volume":"123","author":"Domalpally","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.101028_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2024.100477","article-title":"Strong versus weak data labeling for artificial intelligence algorithms in the measurement of geographic atrophy","volume":"4","author":"Domalpally","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2025.101028_bib22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ophtha.2024.11.017","article-title":"Visual loss in geographic atrophy: learnings from the lampalizumab trials","volume":"132","author":"Anegondi","year":"2025","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.101028_bib23","first-page":"2297","article-title":"Macular tissue integrity index: a novel biomarker for geographic atrophy (GA)","volume":"65","author":"Csaky","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.101028_bib24","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/bjophthalmol-2020-317636","article-title":"Natural history of central sparing in geographic atrophy secondary to non-exudative age-related macular degeneration","volume":"106","author":"Shen","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.101028_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1167\/tvst.13.12.19","article-title":"Band visibility in high-resolution optical coherence tomography assessed with a custom review tool and updated, histology-derived nomenclature","volume":"13","author":"Goerdt","year":"2024","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.xops.2025.101028_bib26","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","article-title":"Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (gather2): 12-month results from a randomised, double-masked, phase 3 trial","volume":"402","author":"Khanani","year":"2023","journal-title":"Lancet"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525003264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525003264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:32:29Z","timestamp":1773981149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914525003264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2666914525003264"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2025.101028","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Study of Macular Preservation and Geographic Atrophy Progression in Age-Related Eye Disease Study 2","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2025.101028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"101028"}}